To include your compound in the COVID-19 Resource Center, submit it here.

ABX464: Additional Phase IIa data

Additional data from the double-blind, Mauritian and Thai Phase IIa ABX464-003 trial in treatment-naive patients with HIV infection showed

Read the full 190 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE